• Phil Taylor
• 04 Apr, 2019

Express Scripts has announced a plan to cut patient co-pays for insulin products at $25 a month ahead of a pricing showdown with US politicians next week. The cap is part of a “patient assurance programme” that the pharmacy benefit manager (PBM) is launching for members of participating non-government funded pharmacy plans managed by Express Scripts, according to its parent company Cigna.
Read more...